Molecular imaging with nanoparticles: giant roles for dwarf actors
10.1007/s00418-008-0511-y
Crossref journal-article
Springer Science and Business Media LLC
Histochemistry and Cell Biology (297)
Bibliography

Debbage, P., & Jaschke, W. (2008). Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochemistry and Cell Biology, 130(5), 845–875.

Authors 2
  1. Paul Debbage (first)
  2. Werner Jaschke (additional)
References 267 Referenced 216
  1. Adler A, Forster N, Homann M, Göringer HU (2008) Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer. Comb Chem High Throughput Screen 11:16–23 (10.2174/138620708783398331) / Comb Chem High Throughput Screen by A Adler (2008)
  2. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5–28 (10.1016/j.jconrel.2004.08.010) / J Control Release by SA Agnihotri (2004)
  3. Alivisatos P (2004) The use of nanocrystals in biological detection. Nat Biotechnol 22:47–52 (10.1038/nbt927) / Nat Biotechnol by P Alivisatos (2004)
  4. Allen MA, Leipold LO, Bulte JWM, Basu G, Zywicke HA, Frank JA, Young M, Douglas T (2005) Paramagnetic viral nanoparticles as potential high-relaxivity MRI contrast agents. Magn Reson Med 54:807–812 (10.1002/mrm.20614) / Magn Reson Med by MA Allen (2005)
  5. Arangoa MA, Ponchel G, Orecchioni AM, Renedo MJ, Duchêne D, Irache JM (2000) Bioadhesive potential of gliadin nanoparticulate systems. Eur J Pharm Sci 11:333–341 (10.1016/S0928-0987(00)00121-4) / Eur J Pharm Sci by MA Arangoa (2000)
  6. Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu Receptor. Cancer Res 63:2723–2727 / Cancer Res by D Artemov (2003)
  7. Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer. Br J Cancer 96:417–423 (10.1038/sj.bjc.6603494) / Br J Cancer by PA Baeuerle (2007)
  8. Bakalova R, Zhelev Z, Aoki I, Kanno I (2007) Designing quantum-dot probes. Nat Photonics 1:487–489 (10.1038/nphoton.2007.150) / Nat Photonics by R Bakalova (2007)
  9. Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K (2005) Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 26:2723–2732 (10.1016/j.biomaterials.2004.07.047) / Biomaterials by S Balthasar (2005)
  10. Benderbous S, Corot C, Jacobs P, Bonnemain B (1996) Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 3(Suppl 2):S292–S294 (10.1016/S1076-6332(96)80560-5) / Acad Radiol by S Benderbous (1996)
  11. Benedum J, Meusch M (1999) Robert Feulgen (1884–1955)—some biographical thoughts. Histochem Cell Biol 111:337–343 (10.1007/s004180050366) / Histochem Cell Biol by J Benedum (1999)
  12. Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PEG (2003) Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 9:355–362 / Clin Cancer Res by ZM Bhujwalla (2003)
  13. Blank M, Weinschenk T, Priemer M, Schluesener H (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276:16464–16468 (10.1074/jbc.M100347200) / J Biol Chem by M Blank (2001)
  14. Boisseau P, Kiparissides C, Pavesio A, Saxl O, Ambrosio L, Benninghofen A, Bigay C–N, Borros S, Briel A, Bruce D, Chabbal J, Charbit F, Coche T, Deacon J, Debbage P, Eaton M, Fuchs H, Fuhr G, Goossens J, Guenther R, Hawlina M, Hofmeister A, Kasemo B, Kirkpatrick J, Kuhn MH, Marche P, Meisel HJ, Mestais C, Moore R, Ogorevc B, Peponnet C, Pieber T, Pirovano D, Puget P, Reinmann M, Riese J, Rodriguez JR, Samitier J, Scherfler H, Schild C, Schmidt S, Schreder S, Souquet J, Subramaniam V, Tavitian B, Venturini P, Vericat JA, von Bally G, Weltring K-M, Williams D, Zivin M (2006) European technology platform on nanomedicine: nanotechnology for health—strategic research agenda. European Commission, Office for Official Publications of the European Communities, Luxembourg, 39 pp. ISBN 92-79-02203-2
  15. Bosi S, Da Ros T, Spalluto G, Prato G (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38:913–923 (10.1016/j.ejmech.2003.09.005) / Eur J Med Chem by S Bosi (2003)
  16. Boulianne GL, Hozumi N, Schulman MJ (1984) Production of functional chimaeric mouse/human antibody region domains. Nature 312:643–646 (10.1038/312643a0) / Nature by GL Boulianne (1984)
  17. Breitz HB, Weiden PL, Beaumier PL, Axworthy DB, Seiler C, Su FM, Graves S, Bryan K, Reno JM (2000) Clinical optimization of pretargeted radioimmunotherapy with antibody–streptavidin conjugate and 90Y-DOTA-biotin. J Nucl Med 41:131–140 / J Nucl Med by HB Breitz (2000)
  18. Brindle KM (2003) Molecular imaging using magnetic resonance: new tools for the development of tumour therapy. Br J Radiol 76:S111–S117 (10.1259/bjr/50577981) / Br J Radiol by KM Brindle (2003)
  19. Brody EN, Gold L (2000) Aptamers as therapeutic and diagnostic agents. J Biotechnol 74:5–13 / J Biotechnol by EN Brody (2000)
  20. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I (2004) Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the American heart association. Circulation 109:2655–2671 (10.1161/01.CIR.0000128587.30041.C8) / Circulation by RD Brook (2004)
  21. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA (2007) Gadodiamide-associated nephorgenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 188:586–592 (10.2214/AJR.06.1094) / Am J Roentgenol by DR Broome (2007)
  22. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191–199 (10.1006/taap.2001.9240) / Toxicol Appl Pharmacol by DM Brown (2001)
  23. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013–2016 (10.1126/science.281.5385.2013) / Science by M Bruchez Jr (1998)
  24. Bruggemann M, Neuberger MS (1996) Strategies for expressing human antibody repertoires in transgenic mice. Immunol Today 17:391–397 (10.1016/0167-5699(96)10025-6) / Immunol Today by M Bruggemann (1996)
  25. Brunner A, Prelog M, Verdorfer I, Tzankov A, Mikuz G, Ensinger C (2008) EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder. J Clin Pathol 61:307–310 (10.1136/jcp.2007.049460) / J Clin Pathol by A Brunner (2008)
  26. Bulte JWM, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147 (10.1038/nbt1201-1141) / Nat Biotechnol by JWM Bulte (2001)
  27. Cai XH, Garen A (1995) Anti-melanoma antibodies from melanoma patients immunized with genetically-modified autologous tumour-cells—selection of specific antibodies from single-chain fv fusion phage libraries. Proc Natl Acad Sci USA 92:6537–6541 (10.1073/pnas.92.14.6537) / Proc Natl Acad Sci USA by XH Cai (1995)
  28. Callaghan PT (1991) Principles of nuclear magnetic resonance microscopy. Oxford University Press, New York (10.1093/oso/9780198539445.001.0001) / Principles of nuclear magnetic resonance microscopy by PT Callaghan (1991)
  29. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shepard HM (1992) Humanization of an Anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA 89:4285–4289 (10.1073/pnas.89.10.4285) / Proc Natl Acad Sci USA by P Carter (1992)
  30. Cerchia L, Ducongé F, Pestourie C, Boulay J, Aissouni Y, Gombert K, Tavitian B, de Franciscis V, Libri D (2005) Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 3:e123 (10.1371/journal.pbio.0030123) / PLoS Biol by L Cerchia (2005)
  31. Chan WCW, Nie S (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281:2016–2018 (10.1126/science.281.5385.2016) / Science by WCW Chan (1998)
  32. Chan P, Yuen T, Ruf F, Gonzalez-Maeso J, Sealfon SC (2005) Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Res 33:e161 (10.1093/nar/gni162) / Nucleic Acids Res by P Chan (2005)
  33. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS (2004a) Pegylated Arg-Gly-Asp peptide: Cu-64 labeling and PET imaging of brain tumor alpha(v)beta(3)-integrin expression. J Nucl Med 45:1776–1783 / J Nucl Med by X Chen (2004)
  34. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS (2004b) MicroPET and autoradiographic imaging of GRP receptor expression with Cu-64-DOTA-Lys(3) bombesin in human prostate adenocarcinoma xenografts. J Nucl Med 45:1390–1397 / J Nucl Med by X Chen (2004)
  35. Chen J, Wiley B, Li Z-Y, Campbell D, Saeki F, Cang H, Au L, Lee J, Li X, Xia Y (2005) Gold nanocages: engineering their structure for biomedical applications. Adv Mater 17:2255–2261 (10.1002/adma.200500833) / Adv Mater by J Chen (2005)
  36. Chester KA, Begent RH, Robson L, Keep P, Pedley RB, Boden JA, Boxer G, Green A, Winter G, Cochet O, Hawkins RE (1994) Phage libraries for the generation of clinically useful antibodies. Lancet 343:455–456 (10.1016/S0140-6736(94)92695-6) / Lancet by KA Chester (1994)
  37. Chotia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ (1989) Conformations of immunoglobulin hypervariable regions. Nature 342:877–883 (10.1038/342877a0) / Nature by C Chotia (1989)
  38. Chu TC, Twu KY, Ellington AD, Levy M (2006a) Aptamer mediated siRNA delivery. Nucleic Acids Res 34(10):e73–e73 (10.1093/nar/gkl388) / Nucleic Acids Res by TC Chu (2006)
  39. Chu TC, Marks JWIII, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M (2006b) Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res 66:5989–5992 (10.1158/0008-5472.CAN-05-4583) / Cancer Res by TC Chu (2006)
  40. Chuang VT, Kragh-Hansen U, Otagiri M (2002) Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 19:569–577 (10.1023/A:1015396825274) / Pharm Res by VT Chuang (2002)
  41. Clancy L, Goodman P, Sinclair H, Dockery DW (2002) Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 360:1210–1214 (10.1016/S0140-6736(02)11281-5) / Lancet by L Clancy (2002)
  42. Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK (1998) Pharmacokinetics and biodistribution of genetically engineered antibodies. Q J Nucl Med 42:225–241 / Q J Nucl Med by D Colcher (1998)
  43. Coons AH (1961) The Beginnings of Immunofluorescence. J Immunol 87:499–503 (10.4049/jimmunol.87.5.499) / J Immunol by AH Coons (1961)
  44. Copland JA, Eghtedari M, Popov VL, Kotov N, Mamedova N, Motamedi M, Oraevsky AA (2004) Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Imaging Biol 6:341–349 (10.1016/j.mibio.2004.06.002) / Mol Imaging Biol by JA Copland (2004)
  45. Croy JE, Brandon T, Komives EA (2004) Two apolipoprotein E mimetic peptides, ApoE(130–149) and ApoE(141–155)2, bind to LRP1. Biochemistry 43:7328–7335 (10.1021/bi036208p) / Biochemistry by JE Croy (2004)
  46. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM (2005) Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 53:999–1005 (10.1002/mrm.20477) / Magn Reson Med by CH Cunningham (2005)
  47. Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, Kissel T, Seeger W (2006) Investigation of the proinflammatory potential of bio-degradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol 215:100–108 (10.1016/j.taap.2006.01.016) / Toxicol Appl Pharmacol by LA Dailey (2006)
  48. D’Amato G (2003) Therapy of allergic bronchial asthma with omalizumab—an anti-IgE monoclonal antibody. Expert Opin Biol Ther 3:371–376 (10.1517/14712598.3.2.371) / Expert Opin Biol Ther by G D’Amato (2003)
  49. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 100:15416–15421 (10.1073/pnas.2136683100) / Proc Natl Acad Sci USA by DA Daniels (2003)
  50. de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, van der Lely AJ, Krenning EP (2005) Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest 28:132–136 / J Endocrinol Invest by WW de Herder (2005)
  51. Dhaneshwar SS, Kandpal M, Gairola N, Kadam SS (2006) Dextran: a promising macromolecular drug carrier. Indian J Pharm Sci 68:705–714 (10.4103/0250-474X.31000) / Indian J Pharm Sci by SS Dhaneshwar (2006)
  52. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C (1999) Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 76:103–109 (10.1016/S0006-3495(99)77182-1) / Biophys J by SJ Dodd (1999)
  53. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA (2004) Nanotoxicology. Occup Environ Med 61:727–728 (10.1136/oem.2004.013243) / Occup Environ Med by K Donaldson (2004)
  54. Donaldson K, Tran L, Jimenez L, Duffin R, Newby D, Mills N, MacNee W, Stone V (2005) Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10 (10.1186/1743-8977-2-10) / Part Fibre Toxicol by K Donaldson (2005)
  55. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A (2006) Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92:5–22 (10.1093/toxsci/kfj130) / Toxicol Sci by K Donaldson (2006)
  56. Duncan R (2005) N-(2-hydroxypropyl)methacrylamide copolymer conjugates. In: Kwon GS (ed) Polymeric drug delivery systems. Marcel Dekker, New York, pp 1–92 / Polymeric drug delivery systems by R Duncan (2005)
  57. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D (1999) Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharm Rev 51:691–743 (10.1016/S0031-6997(24)01426-1) / Pharm Rev by DC Drummond (1999)
  58. Ehrlich P (1900) On immunity with special reference to cell life. Proc R Soc Lond 66:424 (10.1098/rspl.1899.0121) / Proc R Soc Lond by P Ehrlich (1900)
  59. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA (1997) Selective colorometric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277:1078–1081 (10.1126/science.277.5329.1078) / Science by R Elghanian (1997)
  60. Elke M (1995) The centenary of W. C. Roentgen’s discovery: a look at developments in science, clinical radiologic practice and environmental problems. Cell Mol Life Sci 51:637–639 (10.1007/BF01941261) / Cell Mol Life Sci by M Elke (1995)
  61. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822 (10.1038/346818a0) / Nature by AD Ellington (1990)
  62. Ellington AD, Ebright J, Chu T, Levy M (2007) Using aptamers for cell-specific labeling and delivery. In: American Association for Cancer Research education book, American Association for Cancer Research, Philadelphia, pp 51–55
  63. Engberink RDO, van der Pol SMA, Döpp ED, de Vries HE, Blezer ELA (2007) Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 243:467–474 (10.1148/radiol.2432060120) / Radiology by RDO Engberink (2007)
  64. Ezpeleta I, Arango MA, Irache JM, Stainmesse S, Chabenat C, Popineau Y, Orecchioni A-M (1999) Preparation of Ulex europaeus lectin–gliadin nanoparticle conjugtaes and their interaction with gastrointestinal mucus. Int J Pharm 191:25–32 (10.1016/S0378-5173(99)00232-X) / Int J Pharm by I Ezpeleta (1999)
  65. Farokhzad OC, Jon S, Khademhosseini A, Tran T-N, LaVan DA, Langer RL (2004) Nanoparticle–aptamer bioconjugates. A new approach for targeting prostate cancer cells. Cancer Res 64:7668–7672 (10.1158/0008-5472.CAN-04-2550) / Cancer Res by OC Farokhzad (2004)
  66. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R (2006a) Targeted nanoparticle–aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103:6315–6320 (10.1073/pnas.0601755103) / Proc Natl Acad Sci USA by OC Farokhzad (2006)
  67. Farokhzad OC, Karp JM, Langer R (2006b) Nanoparticle–aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 3:311–324 (10.1517/17425247.3.3.311) / Expert Opin Drug Deliv by OC Farokhzad (2006)
  68. Fatouros PP, Corwin FD, Chen Z-J, Broaddus WC, Tatum JL, Kettenmann B, Ge Z, Gibson HW, Russ JL, Leonard AP, Duchamp JC, Dorn HC (2006) In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 240:756–764 (10.1148/radiol.2403051341) / Radiology by PP Fatouros (2006)
  69. Feld M, De Roo M (2003) History of nuclear medicine in Europe. In: Schicha H, Bergdolt K, Ell PJ (eds) (trans: Patton DD). Schattauer, New York, 166 pp
  70. Flenniken ML, Willits DA, Harmsen AL, Liepold LO, Harmsen AG, Young MJ, Douglas T (2006) Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem Biol 13:161–170 (10.1016/j.chembiol.2005.11.007) / Chem Biol by ML Flenniken (2006)
  71. Folkman J (2001) Can mosaic tumor vessels facilitate molecular diagnosis of cancer? Proc Natl Acad Sci USA 98:398–400 (10.1073/pnas.98.2.398) / Proc Natl Acad Sci USA by J Folkman (2001)
  72. Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A, Spizzo G (2008) Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol 61:31–35 (10.1136/jcp.2006.037333) / J Clin Pathol by D Fong (2008)
  73. Forster GJ, Santos EB, Smith-Jones PM, Zanzonico P, Larson SM (2006) Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. J Nucl Med 47:140–149 / J Nucl Med by GJ Forster (2006)
  74. Foster-Gareau P, Heyn C, Alejski A, Rutt BK (2003) Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 49:968–971 (10.1002/mrm.10417) / Magn Reson Med by P Foster-Gareau (2003)
  75. Frangioni JV, Hajjar RJ (2004) In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110:3378–3383 (10.1161/01.CIR.0000149840.46523.FC) / Circulation by JV Frangioni (2004)
  76. Frey A, Neutra MR, Robey FA (1997) Peptomer aluminum oxide nanoparticle conjugates as systemic and mucosal vaccine candidates: synthesis and characterization of a conjugate derived from the C4 domain of HIV-1MN gp120. Bioconjug Chem 8:424–433 (10.1021/bc970036p) / Bioconjug Chem by A Frey (1997)
  77. Frey A, Mantis N, Kozlowski PA, Quayle AJ, Bajardi A, Perdomo JJ, Robey FA, Neutra MR (1998) Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles. Vaccine 17:3007–3019 (10.1016/S0264-410X(99)00163-2) / Vaccine by A Frey (1998)
  78. Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S (2003) In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res 9:6551–6559 / Clin Cancer Res by A Gabizon (2003)
  79. Gao J, Hillebrenner HL (2008) Nanotubular probes as ultrasensitive MR contrast agent. US Patent Application 20,080,124,281
  80. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–976 (10.1038/nbt994) / Nat Biotechnol by XH Gao (2004)
  81. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S (2005) In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16:63–72 (10.1016/j.copbio.2004.11.003) / Curr Opin Biotechnol by X Gao (2005)
  82. Gavilondo JV, Larrick JW (2000) Antibody engineering at the millennium. Biotechniques 29:128–146 (10.2144/00291ov01) / Biotechniques by JV Gavilondo (2000)
  83. Gilmour PS, Ziesenis A, Morrison ER, Vickers MA, Drost EM, Ford I, Karg E, Mossa C, Schroeppel A, Ferron GA, Heyder J, Greaves M, MacNee W, Donaldson K (2004) Pulmonary and system effects of short-term inhalation exposure to ultrafine carbon black particles. Toxicol Appl Pharmacol 195:35–44 (10.1016/j.taap.2003.10.003) / Toxicol Appl Pharmacol by PS Gilmour (2004)
  84. Gradishar W, Krasnojon D, Cheporov S, Makhson A, Manikhas G, Clawson A, Hawkins MJ (2006) A randomized phase 2 trial of qw or q3w ABI-007 (ABX) vs q3w solvent-based docetaxel (TXT) as first-line therapy in metastatic breast cancer (MBC). Presented at 29th Annual San Antonio Breast Cancer Symposium, San Antonio, December 14–17, 2006, Texas, Abstract 46
  85. Haes AJ, Van Duyne RP (2002) A nanoscale optical biosensor: sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles. J Am Chem Soc 124:10596–10604 (10.1021/ja020393x) / J Am Chem Soc by AJ Haes (2002)
  86. Hardman R (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165–172 (10.1289/ehp.8284) / Environ Health Perspect by R Hardman (2006)
  87. Hattori Y, Kawakami S, Nakamura K, Yamashita F, Hashida M (2006) Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J Pharm Exp Ther 318:828–834 (10.1124/jpet.106.105098) / J Pharm Exp Ther by Y Hattori (2006)
  88. Heidel JD, Yu Z, Liu JYC, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME (2007) Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA 104:5715–5721 (10.1073/pnas.0701458104) / Proc Natl Acad Sci USA by JD Heidel (2007)
  89. Hellings WE, Peeters W, Moll F, Pasterkamp G (2007) From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med 17:162–171 (10.1016/j.tcm.2007.03.006) / Trends Cardiovasc Med by WE Hellings (2007)
  90. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AR, Rutt BK, Foster PJ (2006) In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55:23–29 (10.1002/mrm.20747) / Magn Reson Med by C Heyn (2006)
  91. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook G, Warren S, Schmidt PG (2006) Tumor targeting by an aptamer. J Nucl Med 47:668–678 / J Nucl Med by BJ Hicke (2006)
  92. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE (2003) Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102:867–872 (10.1182/blood-2002-12-3669) / Blood by KA Hinds (2003)
  93. Hirabayashi H, Fujisaki J (2003) Bone specific drug delivery systems: approaches via chemical modification of bone-seeking agents. Clin Pharmacokinet 42:1319–1330 (10.2165/00003088-200342150-00002) / Clin Pharmacokinet by H Hirabayashi (2003)
  94. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99:16267–16272 (10.1073/pnas.242435499) / Proc Natl Acad Sci USA by M Hoehn (2002)
  95. Hofheinz RD, al-Batran SE, Hartmann F, Hartung G, Jäger D, Renner C, Tanswell P, Kunz U, Amelsberg A, Kuthan H, Stehle G (2003) Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie 26:44–48 (10.1159/000069863) / Onkologie by RD Hofheinz (2003)
  96. Homann M, Goringer HU (1999) Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 27:2006–2014 (10.1093/nar/27.9.2006) / Nucleic Acids Res by M Homann (1999)
  97. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, Suzuki K, Yasuhara M, Yamamoto K (2004) Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 48:985–994 (10.1111/j.1348-0421.2004.tb03621.x) / Microbiol Immunol by A Hoshino (2004)
  98. Huang JZ, Frischer JS, New T, Kim ES, Serur A, Lee A, Kadenhe-Chiwishe A, Pollyea DA, Yokoi A, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ (2004) TNP-470 promotes initial vascular sprouting in xenograft tumors. Mol Cancer Ther 3:335–343 (10.1158/1535-7163.335.3.3) / Mol Cancer Ther by JZ Huang (2004)
  99. Huang YF, Lin YW, Lin Z-H, Chang HT (2008a) Aptamer-modified gold nanoparticles for targeting breast cancer cells through light scattering. J Nanoparticle Res. doi:10.1007/s11051-008-9424-x (10.1007/s11051-008-9424-x)
  100. Huang YF, Chang HT, Tan W (2008b) Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 80:567–572 (10.1021/ac702322j) / Anal Chem by YF Huang (2008)
  101. Hudson PJ, Souriau C (2003) Engineered antibodies. Nat Med 9:129–134 (10.1038/nm0103-129) / Nat Med by PJ Hudson (2003)
  102. Hung CT, McLeod AD, Gupta PK (1990) Formulation and characterization of magnetic polyglutaraldehyde nanoparticles as carriers for poly-l-lysine-methotrexate. Drug Dev Ind Pharm 16:509–521 (10.3109/03639049009114899) / Drug Dev Ind Pharm by CT Hung (1990)
  103. Iinuma H, Maruyama K, Okinaga K, Sasaki K, Sekine T, Ishida O, Ogiwara N, Johkura K, Yonemura Y (2002) Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 99:130–137 (10.1002/ijc.10242) / Int J Cancer by H Iinuma (2002)
  104. Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M (2007) Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 25:319–325 (10.1200/JCO.2006.07.8824) / J Clin Oncol by JR Infante (2007)
  105. Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T (2003) Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. Clin Cancer Res 9:886–899 / Clin Cancer Res by K Inoue (2003)
  106. Isaacs JD (1990) The antiglobulin response to therapeutic antibodies. Semin Immunol 2:449–456 / Semin Immunol by JD Isaacs (1990)
  107. Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. JAMA 293:855–862 (10.1001/jama.293.7.855) / JAMA by FA Jaffer (2005)
  108. Jani P, Halbert GW, Langridge J, Florence AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42:821–826 (10.1111/j.2042-7158.1990.tb07033.x) / J Pharm Pharmacol by P Jani (1990)
  109. Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R (2004) A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem 279:48410–48419 (10.1074/jbc.M409059200) / J Biol Chem by SH Jeon (2004)
  110. Jin X, Xu M, Wang LV, Fang YR, Zanelli CI, Howard M (2005) Imaging of HIFU-induced lesions in soft biological tissue using thermoacoustic tomography. Med Phys 32:5–11 (10.1118/1.1829403) / Med Phys by X Jin (2005)
  111. John TA, Vogel SM, Tiruppathi TC, Malik AB, Minshall RD (2003) Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 284:L187–L196 (10.1152/ajplung.00152.2002) / Am J Physiol Lung Cell Mol Physiol by TA John (2003)
  112. Jung CW (1995) Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13:675–691 (10.1016/0730-725X(95)00023-A) / Magn Reson Imaging by CW Jung (1995)
  113. Kabat EA, Wu TT, Bilofsky H, Reid-Miller, Perry HM (1991) Sequences of proteins of immunological interest, NIH Publication No. 369-847. NIH, Bethesda. http://www.kabatdatabase.com/index.html
  114. Karpas A, Dremucheva A, Czepulkowski BH (2001) A human myeloma cell line suitable for the generation of human monoclonal antibodies. Proc Natl Acad Sci USA 98:1799–1804 (10.1073/pnas.98.4.1799) / Proc Natl Acad Sci USA by A Karpas (2001)
  115. Keefe AD, Schaub RG (2008) Aptamers as candidate therapeutics for cardiovascular indications. Curr Opin Pharmacol 8:147–152 (10.1016/j.coph.2007.12.005) / Curr Opin Pharmacol by AD Keefe (2008)
  116. Kellermann SA, Green LL (2002) Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics. Curr Opin Biotechnol 13:593–597 (10.1016/S0958-1669(02)00354-3) / Curr Opin Biotechnol by SA Kellermann (2002)
  117. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV (2003) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93–97 (10.1038/nbt920) / Nat Biotechnol by S Kim (2003)
  118. Kipen HM, Laskin DL (2005) Smaller is not always better: nanotechnology yields nanotoxicology. Am J Physiol Lung Cell Mol Physiol 289:L696–L697 (10.1152/ajplung.00277.2005) / Am J Physiol Lung Cell Mol Physiol by HM Kipen (2005)
  119. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003) In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63:6838–6846 / Cancer Res by MF Kircher (2003)
  120. Kish PE, Tsume Y, Kijek P, Lanigan TM, Hilfinger JM, Roessler BJ (2006) Bile acid–oligopeptide conjugates interact with DNA and facilitate transfection. Mol Pharm 4:95–103 (10.1021/mp060025q) / Mol Pharm by PE Kish (2006)
  121. Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL (2005) Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia 7:984–991 (10.1593/neo.05454) / Neoplasia by H Kobayashi (2005)
  122. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497 (10.1038/256495a0) / Nature by G Köhler (1975)
  123. Kreuter J (2002) Transport of drugs across the blood-brain barrier by nanoparticles. Curr Med Chem Central Nervous Syst Agents 2:241–249 (10.2174/1568015023357950) / Curr Med Chem Central Nervous Syst Agents by J Kreuter (2002)
  124. Kruger RA, Stantz KM, Kiser WL (2002) Thermoacoustic CT of the breast. Proc SPIE 4682:521–525 (10.1117/12.465596) / Proc SPIE by RA Kruger (2002)
  125. Kruger RA, Kiser WL, Reinecke DR, Kruger GA, Miller KD (2003) Thermoacoustic molecular imaging of small animals. Mol Imaging 2(2):113–123 (10.1162/153535003322331993) / Mol Imaging by RA Kruger (2003)
  126. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242:647–649 (10.1148/radiol.2423061640) / Radiology by PH Kuo (2007)
  127. Lam C-W, James JT, McCluskey R, Hunter RL (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134 (10.1093/toxsci/kfg243) / Toxicol Sci by C-W Lam (2004)
  128. Lanman J, Crum J, Deerinck T, Gaietta GM, Schneemann A, Sosinsky GE, Ellisman MH, Johnson JE (2008) Visualizing flock house virus infection in Drosophila cells with correlated fluorescence and electron microscopy. J Struct Biol 161(3):439–446 (10.1016/j.jsb.2007.09.009) / J Struct Biol by J Lanman (2008)
  129. Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett FD, Wickline SA (2005) 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr Top Dev Biol 70:57–76 (10.1016/S0070-2153(05)70003-X) / Curr Top Dev Biol by GM Lanza (2005)
  130. Laufer J, Elwell C, Delpy D, Beard P (2005) In vitro measurements of absolute blood oxygen saturation using pulsed near-infrared photoacoustic spectroscopy: accuracy and resolution. Phys Med Biol 50(18):4409–4428 (10.1088/0031-9155/50/18/011) / Phys Med Biol by J Laufer (2005)
  131. Lauterbur PC (1973) Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242:190–191 (10.1038/242190a0) / Nature by PC Lauterbur (1973)
  132. Lee CC, MacKay JA, Fréchet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517–1526 (10.1038/nbt1171) / Nat Biotechnol by CC Lee (2005)
  133. Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13:95–99 (10.1038/nm1467) / Nat Med by JH Lee (2007)
  134. Lee J, Kim J, Park E, Jo S, Song R (2008) PEG-ylated cationic CdSe/ZnS QDs as an efficient intracellular labeling agent. Phys Chem Chem Phys 10:1739–1742 (10.1039/b801317a) / Phys Chem Chem Phys by J Lee (2008)
  135. Letsinger RL, Mirkin CA, Park SJ, Viswanadham G, Zhang L (2001) Poly(oligonucleotide) conjugates: applications in assembling nanoparticles and in detecting DNA sequences. Nucl Acids Res Suppl (1):1–2 (10.1093/nass/1.1.1)
  136. Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H (2006) Viral nanoparticles as tools for intravital vascular imaging. Nat Med 12:354–360 (10.1038/nm1368) / Nat Med by JD Lewis (2006)
  137. Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco HE, Jares-Erijman EA, Jovin TM (2004) Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 22:198–203 (10.1038/nbt929) / Nat Biotechnol by DS Lidke (2004)
  138. Lindner JR (2002) Evolving applications for contrast ultrasound. Am J Cardiol 90:72–80 (10.1016/S0002-9149(02)02951-X) / Am J Cardiol by JR Lindner (2002)
  139. Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450:56–62 (10.1038/nature06293) / Nature by J Livet (2007)
  140. Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029–4033 / Cancer Res by SE Lupold (2002)
  141. Lutz JF, Börner HG, Weichenhan K (2007) ‘Click’ bioconjugation of a well-defined synthetic polymer and a protein transduction domain. Aust J Chem 60:410–413 (10.1071/CH07052) / Aust J Chem by JF Lutz (2007)
  142. Mansfield P, Grannell PK (1973) NMR ‘diffraction’ in solids? J Phys C Solid State Phys 6:L422–L426 (10.1088/0022-3719/6/22/007) / J Phys C Solid State Phys by P Mansfield (1973)
  143. Mason WT (ed) (1999) Fluorescent and luminescent probes for biological activity. Academic Press, London
  144. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580 (10.1101/gad.1047403) / Genes Dev by TF Massoud (2003)
  145. McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552–554 (10.1038/348552a0) / Nature by J McCafferty (1990)
  146. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150:552–558 (10.1038/sj.bjp.0707130) / Br J Pharmacol by C Medina (2007)
  147. Mendez MJ, Green LL, Corvalan JRF, Jia XC, Maynard-Curie CE, Yang XD, Gallo ML, Louie DM, Lee DV, Erickson KL, Luna J, Roy CMN, Abderrahim H, Kirschenbaum F, Noguchi M, Smith DH, Fukushima A, Hales JF, Finer MH, Davis CG, Zsebo KM, Jakobovits A (1997) Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 15:146–156 (10.1038/ng0297-146) / Nat Genet by MJ Mendez (1997)
  148. Meresse S, Delbart C, Fruchart JC, Cecchelli R (1989) Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem 53:340–345 (10.1111/j.1471-4159.1989.tb07340.x) / J Neurochem by S Meresse (1989)
  149. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14:1851–1858 (10.1007/s00330-004-2405-2) / Eur Radiol by S Metz (2004)
  150. Meyer DL, Schultz J, Lin Y, Henry A, Sanderson J, Jackson JM, Goshorn S, Rees AR, Graves SS (2001) Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci 10:491–503 (10.1110/ps.19901) / Protein Sci by DL Meyer (2001)
  151. Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K (2006) Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain: J Pharmacol Exp Ther 317:1246–1253 (10.1124/jpet.105.097139) / J Pharmacol Exp Ther by K Michaelis (2006)
  152. Minshall RD, Sessa WC, Stan RV, Anderson RGW, Malik AB (2003) Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285:L1179–L1183 (10.1152/ajplung.00242.2003) / Am J Physiol Lung Cell Mol Physiol by RD Minshall (2003)
  153. Mitra A, Nan A, Papadimitriou JC, Ghandehari H, Line BR (2006) Polymer–peptide conjugates for angiogenesis targeted tumor radiotherapy. Nucl Med Biol 33:43–52 (10.1016/j.nucmedbio.2005.09.005) / Nucl Med Biol by A Mitra (2006)
  154. Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–478 (10.1016/S0163-7827(03)00033-X) / Prog Lipid Res by SM Moghimi (2003)
  155. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318 (10.1016/S0031-6997(24)01494-7) / Pharmacol Rev by SM Moghimi (2001)
  156. Morris KN, Jensen KB, Julin CM, Weil M, Gold L (1998) High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci USA 95:2902–2907 (10.1073/pnas.95.6.2902) / Proc Natl Acad Sci USA by KN Morris (1998)
  157. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 81:6851–6855 (10.1073/pnas.81.21.6851) / Proc Natl Acad Sci USA by SL Morrison (1984)
  158. Mulder WJM, Strijkers GJ, Habets JW, Bleeker EJW, van der Schaft DWJ, Storm G, Koning GA, Griffioen AW, Nicolay K (2005) MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 19:2008–2010 (10.1096/fj.05-4145fje) / FASEB J by WJM Mulder (2005)
  159. Mulisch M, Welsch U (Hrsg) (2008) Romeis—mikroskopische technik, 18th edn. Spektrum Akademischer. ISBN: 978-3-8274-1676-6
  160. Nabhan C, Dyer M, Rosen S (2003) Current status of monclonal antibody therapy for chronic lymphocytic leukaemia. Oncology (Huntingt) 17:253–262 discussion 264, 267 / Oncology (Huntingt) by C Nabhan (2003)
  161. Nelson KL, Runge VM (1995) Basic principles of MR contrast. Top Magn Reson Imaging 7:124–136 (10.1097/00002142-199500730-00002) / Top Magn Reson Imaging by KL Nelson (1995)
  162. Niederhauser J (2004) Real-time biomedical optoacoustic imaging. Diss ETH No.15572
  163. Nimpf J, Schneider WJ (2000) From cholesterol transport to signal transduction: low density lipoprotein receptor, very low density lipoprotein receptor and apolipoprotein E receptor-2. Biochim Biophys Acta 1529:287–298 (10.1016/S1388-1981(00)00155-4) / Biochim Biophys Acta by J Nimpf (2000)
  164. Oberdörster E (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112:1058–1062 (10.1289/ehp.7021) / Environ Health Perspect by E Oberdörster (2004)
  165. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005a) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8 (10.1186/1743-8977-2-8) / Part Fibre Toxicol by G Oberdörster (2005)
  166. Oberdörster G, Oberdörster E, Oberdörster J (2005b) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839 (10.1289/ehp.7339) / Environ Health Perspect by G Oberdörster (2005)
  167. Ohsawa K, Kasamatsu T, Nagashima JI, Hanawa K, Kuwahara M, Ozaki H, Sawai H (2008) Arginine-modified DNA aptamers that show enantioselective recognition of the dicarboxylic acid moiety of glutamic acid. Anal Sci 24:167–172 (10.2116/analsci.24.167) / Anal Sci by K Ohsawa (2008)
  168. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE (2004) EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64:5818–5824 (10.1158/0008-5472.CAN-04-0754) / Cancer Res by WA Osta (2004)
  169. Pagona G, Tagmatarchis N (2006) Carbon nanotubes: materials for medicinal chemistry and biotechnological applications. Curr Med Chem 3:1789–1798 (10.2174/092986706777452524) / Curr Med Chem by G Pagona (2006)
  170. Pan Q, Zhang XL, Wu HY, He PW, Wang F, Zhang MS, Hu JM, Xia B, Wu J (2005) Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar Typhi. Antimicrob Agents Chemother 49:4052–4060 (10.1128/AAC.49.10.4052-4060.2005) / Antimicrob Agents Chemother by Q Pan (2005)
  171. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21:1647–1654 (10.1096/fj.06-6505com) / FASEB J by KC Partlow (2007)
  172. Paschkunova-Martic I, Kremser C, Mistlberger K, Shcherbakova N, Dietrich H, Talasz H, Zou Y, Hugl B, Galanski M, Sölder E, Pfaller K, Höliner I, Buchberger W, Keppler B, Debbage P (2005) Design, synthesis, physical and chemical characterization, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI). Histochem Cell Biol 123:283–301 (10.1007/s00418-005-0780-7) / Histochem Cell Biol by I Paschkunova-Martic (2005)
  173. Pericleous LM, Richards J, Epenetos AA, Courtenay-Luck N, Deonarain MP (2005) Characterisation and internalisation of recombinant humanised HMFg-1 antibodies against MUC1. Br J Cancer 93:1257–1266 (10.1038/sj.bjc.6602847) / Br J Cancer by LM Pericleous (2005)
  174. Peters A, Pope CAIII (2002) Cardiopulmonary mortality and air pollution. Lancet 360:1184–1185 (10.1016/S0140-6736(02)11289-X) / Lancet by A Peters (2002)
  175. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 262:14352–14360 (10.1016/S0021-9258(18)47945-8) / J Biol Chem by RE Pitas (1987)
  176. Pomper MG (2005) Translational molecular imaging for cancer. Cancer Imaging 5:S16–S26 (10.1102/1470-7330.2005.0101) / Cancer Imaging by MG Pomper (2005)
  177. Pope CA (2001) Particulate air pollution, C-reactive protein, and cardiac risk. Eur Heart J 22:1149–1150 (10.1053/euhj.2001.2593) / Eur Heart J by CA Pope (2001)
  178. Posey JA, Saif MW, Carlisle R, Goetz A, Rizzo J, Stevenson S, Rudoltz MS, Kwiatek J, Simmons P, Rowinsky EK, Takimoto CH, Tolcher AW (2005) Phase 1 study of weekly polyethylene glycol–camptothecin in patients with advanced solid tumors and lymphomas. Clin Cancer Res 11:7866–7871 (10.1158/1078-0432.CCR-05-0783) / Clin Cancer Res by JA Posey (2005)
  179. Predescu D, Vogel SM, Malik AB (2004) Functional and morphological studies of protein transcytosis in continuous endothelia. Am J Physiol Lung Cell Mol Physiol 287:L895–L901 (10.1152/ajplung.00075.2004) / Am J Physiol Lung Cell Mol Physiol by D Predescu (2004)
  180. Presta LG, Lahr SJ, Shields RL, Porter JP, Gorman CM, Fendly BM, Jardieu PM (1993) Humanization of an antibody directed against IgE. J Immunol 151:2623–2632 (10.4049/jimmunol.151.5.2623) / J Immunol by LG Presta (1993)
  181. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R (2006) An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 5:118–122 (10.1038/nmat1571) / Nat Mater by O Rabin (2006)
  182. Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, Karpilow J, Marshall WS, Khvorova A (2006) Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12:988–993 (10.1261/rna.2340906) / RNA by A Reynolds (2006)
  183. Ribalta J, Vallve JC, Girona J, Masana L (2003) Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care 6:177–187 (10.1097/00075197-200303000-00006) / Curr Opin Clin Nutr Metab Care by J Ribalta (2003)
  184. Riechmann L, Clark MR, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323–327 (10.1038/332323a0) / Nature by L Riechmann (1988)
  185. Rofsky NM, Sherry AD, Lenkinski RE (2008) Nephrogenic systemic fibrosis: a chemical perspective. Radiology 247:608–612 (10.1148/radiol.2473071975) / Radiology by NM Rofsky (2008)
  186. Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ (2005) 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 46:1210–1218 / J Nucl Med by R Rossin (2005)
  187. Roth J (1983) The colloidal gold marker system for light and electron microscopy. Theory and application. In: Bullock GR, Petrusz P (eds) Techniques in immunocytochemistry, vol II. Academic Press, London, pp 217–284
  188. Routledge EG, Gorman SD, Clark M (1993) Reshaping antibodies for therapy. In: Clark M (ed) Protein engineering of antibody molecules for prophylactic and therapeutic applications in man. Academic Titles, Nottingham, pp 13–44. ISBN: 1-874695-00-8
  189. Runge VM, Wells JW (1995) Update: safety, new applications, new MR agents. Top Magn Reson Imaging 7:181–195 / Top Magn Reson Imaging by VM Runge (1995)
  190. Salvi SS, Nordenhall C, Blomberg A, Rudell B, Pourazar J, Kelly FJ, Wilson S, Sandström T, Holgate ST, Frew AJ (2000) Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med 161:550–557 (10.1164/ajrccm.161.2.9905052) / Am J Respir Crit Care Med by SS Salvi (2000)
  191. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J (2004) Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 10:255–261 (10.1038/nm1002) / Nat Med by R Satchi-Fainaro (2004)
  192. Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV, Woodle MC (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 32:e149 (10.1093/nar/gnh140) / Nucleic Acids Res by RM Schiffelers (2004)
  193. Schluep T, Cheng JJ, Khin KT, Davis ME (2006a) Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Cancer Chem Pharmacol 57:654–662 (10.1007/s00280-005-0091-7) / Cancer Chem Pharmacol by T Schluep (2006)
  194. Schluep T, Hwang J, Cheng JJ, Heidel JD, Bartlett DW, Hollister B, Davis ME (2006b) Preclinical efficacy of the camptothecin–polymer conjugate IT-101 in multiple cancer models. Clin Cancer Res 12:1606–1614 (10.1158/1078-0432.CCR-05-1566) / Clin Cancer Res by T Schluep (2006)
  195. Schnyder A, Krähenbühl S, Drewe J, Huwyler J (2005) Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects. J Drug Target 13:325–335 (10.1080/10611860500206674) / J Drug Target by A Schnyder (2005)
  196. Schubert W, Frank PG, Chow CW, Lisanti MP (2001) Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 276:48619–48622 (10.1074/jbc.C100613200) / J Biol Chem by W Schubert (2001)
  197. Schvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, Maynard A, Baron P (2003) Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 66:1909–1926 (10.1080/713853956) / J Toxicol Environ Health A by AA Schvedova (2003)
  198. Scott AM, Lee FT, Jones R, Hopkins W, MacGregor D, Cebon JS, Hannah A, Chong G, U P, Papenfuss A, Rigopoulos A, Sturrock S, Murphy R, Wirth V, Murone C, Smyth FE, Knight S, Welt S, Ritter G, Richards E, Nice EC, Burgess AW, Old LJ (2005) A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake. Clin Cancer Res 11:4810–4817 (10.1158/1078-0432.CCR-04-2329) / Clin Cancer Res by AM Scott (2005)
  199. Seaton A, Donaldson K (2005) Nanoscience, nanotoxicology, and the need to think small. Lancet 365:923–924 (10.1016/S0140-6736(05)71061-8) / Lancet by A Seaton (2005)
  200. Seibert JA, Boone JM (2005) X-ray imaging physics for nuclear medicine technologists. Part 2: X-ray interactions and image formation. J Nucl Med Technol 33:3–18 / J Nucl Med Technol by JA Seibert (2005)
  201. Service RF (2004) Nanotoxicology: nanotechnology grows up. Science 304:1732–1734 (10.1126/science.304.5678.1732) / Science by RF Service (2004)
  202. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838–11843 (10.1073/pnas.0602615103) / Proc Natl Acad Sci USA by D Shangguan (2006)
  203. Shapiro EM, Skrtic S, Koretsky AP (2005) Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 53:329–338 (10.1002/mrm.20342) / Magn Reson Med by EM Shapiro (2005)
  204. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484 (10.1002/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E) / J Magn Reson Imaging by FG Shellock (1999)
  205. Shiokawa T, Hattori Y, Kawano K, Ohguchi Y, Kawakami H, Toma K, Maitani Y (2005) Effect of polyethyelne glycol linker chain length of folate-linked microemulsions loading Aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res 11:2018–2025 (10.1158/1078-0432.CCR-04-1129) / Clin Cancer Res by T Shiokawa (2005)
  206. Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M, Gabizon A (2006) Intracelllular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with upregulated folate receptors. Mol Cancer Ther 5:818–824 (10.1158/1535-7163.MCT-05-0543) / Mol Cancer Ther by H Shmeeda (2006)
  207. Singer JW (2005) Paclitaxel poliglumex (XYOTAX TM, CT-2103): a macromolecular taxane. J Control Release 109:120–126 (10.1016/j.jconrel.2005.09.033) / J Control Release by JW Singer (2005)
  208. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, Bergami A, Zyroff J, Scotti G, Comi G (1999) Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 17:1521–1523 (10.1016/S0730-725X(99)00085-5) / Magn Reson Imaging by JC Sipe (1999)
  209. Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J (2004) Demystified…recombinant antibodies. J Clin Pathol 57:912–917 (10.1136/jcp.2003.014407) / J Clin Pathol by KA Smith (2004)
  210. Smith J, Kontermann RE, Embleton J, Kumar S (2005) Antibody phage display technologies with special reference to angiogenesis. FASEB J 19:331–341 (10.1096/fj.04-2863rev) / FASEB J by J Smith (2005)
  211. Steerenberg PA, Zonnenberg JA, Dormans JA, Joon PN, Wouters IM, van Bree L, Scheepers PTJ, van Loveren H (1998) Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS 2B) in vitro. Exp Lung Res 24:85–100 (10.3109/01902149809046056) / Exp Lung Res by PA Steerenberg (1998)
  212. Stern M, Herrmann R (2005) Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol 54:11–29 (10.1016/j.critrevonc.2004.10.011) / Crit Rev Oncol Hematol by M Stern (2005)
  213. Stockwin LH, Holmes S (2003) The role of therapeutic antibodies in drug discovery. Biochem Soc Trans 31:433–436 (10.1042/BST0310433) / Biochem Soc Trans by LH Stockwin (2003)
  214. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications: reflections on the field. Adv Drug Deliv Rev 57:2106–2129 (10.1016/j.addr.2005.09.018) / Adv Drug Deliv Rev by S Svenson (2005)
  215. Szellas T, Hoppe M (2007) Breaking the barriers in bio research. Imaging Microsc 9:26–27 (10.1002/imic.200790114) / Imaging Microsc by T Szellas (2007)
  216. Tanenbaum LN (2006) Clinical 3T MR imaging: mastering the challenges. Magn Reson Imaging Clin North Am 14:1–15 (10.1016/j.mric.2005.12.004) / Magn Reson Imaging Clin North Am by LN Tanenbaum (2006)
  217. Teply BA, Rocha FG, Levy-Nissenbaum E, Langer R, Farokhzad OC (2006) Nanoparticle-aptamer bioconjugates for targeted antineoplastic drug delivery. Am J Drug Deliv 4:123–130 (10.2165/00137696-200604030-00001) / Am J Drug Deliv by BA Teply (2006)
  218. Ter-Pogossian MM (1985) PET, SPECT, and NMRT: competing or complementary disciplines? J Nucl Med 26:1487–1498 / J Nucl Med by MM Ter-Pogossian (1985)
  219. Thistlethwaite JR Jr, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS (1984) Evolving use of OKT3 monoclonal antibody for treatment of renal allogrft rejection. Transplantation 38:695–700 (10.1097/00007890-198412000-00029) / Transplantation by JR Thistlethwaite Jr (1984)
  220. Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL (2000) Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res 6:1140–1149 / Clin Cancer Res by R Thomas (2000)
  221. Tian H (2002) Combinatorial selection of RNA ligands for complex cellular targets: the RNA ligands-based proteomics. Mol Cell Proteomics 1:99–103 (10.1074/mcp.T100002-MCP200) / Mol Cell Proteomics by H Tian (2002)
  222. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB (1997) Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 272:25968–25975 (10.1074/jbc.272.41.25968) / J Biol Chem by C Tiruppathi (1997)
  223. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510 (10.1126/science.2200121) / Science by C Tuerk (1990)
  224. Tuma PL, Hubbard AL (2003) Transcytosis: crossing cellular barriers. Physiol Rev 83:871–932 (10.1152/physrev.00001.2003) / Physiol Rev by PL Tuma (2003)
  225. Ulrich H, Magdesian MH, Alves MJM, Colli W (2002) In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 277:20756–20762 (10.1074/jbc.M111859200) / J Biol Chem by H Ulrich (2002)
  226. van Loghem E (1986) Allotypic markers. Monogr Allergy 19:40–51 / Monogr Allergy by E van Loghem (1986)
  227. Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R, Thomson AH, Murray LS, Hilditch TE, Murray T, Burtles S, Fraier D, Frigerio E, Cassidy J (1999) Phase I clinical and pharmacokinetic study of PK1 N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin: first member of a new class of chemotherapeutic agents—drug–polymer conjugates. Clin Cancer Res 5:83–94 / Clin Cancer Res by PA Vasey (1999)
  228. Vasile E, Simionescu M, Simionescu N (1983) Visualization of the binding, endocytosis and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 96:1677–1689 (10.1083/jcb.96.6.1677) / J Cell Biol by E Vasile (1983)
  229. Vaughn TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS (1996) Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 14:309–314 (10.1038/nbt0396-309) / Nat Biotechnol by TJ Vaughn (1996)
  230. Vicent MJ (2007) Polymer–drug conjugates as modulators of cellular apoptosis. AAPS J 9:E200–E207 (10.1208/aapsj0902022) / AAPS J by MJ Vicent (2007)
  231. Vitaliti A, Wittmer R, Steiner R, Wyder L, Neri D, Klemenz R (2000) Inhibition of tumor angiogenesis by a single chain antibody directed against vascular endothelial growth factor. Cancer Res 60:4311–4314 / Cancer Res by A Vitaliti (2000)
  232. Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C, Malik AB (2001) Albumin update and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 281:L1512–L1522 (10.1152/ajplung.2001.281.6.L1512) / Am J Physiol Lung Cell Mol Physiol by SM Vogel (2001)
  233. Vogel V, Langer K, Balthasar S, Schuck P, Mächtle W, Haase W, van den Broek JA, Tziatzios C, Schubert D (2002) Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy. Progr Colloid Polym Sci 119:31–36 (10.1007/3-540-44672-9_5) / Progr Colloid Polym Sci by V Vogel (2002)
  234. Waldmann TA (2003) Immunotherapy: past, present and future. Nat Med 9:269–277 (10.1038/nm0303-269) / Nat Med by TA Waldmann (2003)
  235. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319–2331 (10.1007/s003300100908) / Eur Radiol by YX Wang (2001)
  236. Wang XD, Pang YJ, Ku G, Xie XY, Stoica G, Wang LV (2003) Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain. Nat Biotechnol 21:803–806 (10.1038/nbt839) / Nat Biotechnol by XD Wang (2003)
  237. Wang X, Xie X, Ku G, Stoica G, Wang LV (2006) Non-invasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. J Biomed Opt 11:1–9 / J Biomed Opt by X Wang (2006)
  238. Wang AZ, Bagalkot V, Gu F, Alexis F, Vasilliou C, Cima M, Jon S, Farokhzad O (2007) Novel targeted aptamer–superparamagnetic iron oxide nanoparticle bioconjugates for combined prostate cancer imaging and therapy. Int J Rad Oncol Biol Phys 69(Suppl 1):S110–S111 (10.1016/j.ijrobp.2007.07.203) / Int J Rad Oncol Biol Phys by AZ Wang (2007)
  239. Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K (2004) Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Target 12:461–471 (10.1080/10611860400010697) / J Drug Target by H Wartlick (2004)
  240. Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG (2005) Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fatty Acids 72:267–272 (10.1016/j.plefa.2004.12.003) / Prostaglandins Leukot Essent Fatty Acids by G Watkins (2005)
  241. Weisgraber KH (1994) Apolipoprotein E: structure–function relationships. Adv Protein Chem 45:249–302 (10.1016/S0065-3233(08)60642-7) / Adv Protein Chem by KH Weisgraber (1994)
  242. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333 (10.1148/radiology.219.2.r01ma19316) / Radiology by R Weissleder (2001)
  243. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580–589 (10.1038/nature06917) / Nature by R Weissleder (2008)
  244. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489–493 (10.1148/radiology.175.2.2326474) / Radiology by R Weissleder (1990)
  245. Wickline SA, Lanza GM (2003) Nanotechnology for molecular imaging and targeted therapy. Circulation 107:1092–1095 (10.1161/01.CIR.0000059651.17045.77) / Circulation by SA Wickline (2003)
  246. Wieser E, Strohmeyer D, Rogatsch H, Horninger W, Bartsch G, Debbage P (2004) Access of tumor-derived macromolecules and cells to the blood: an electron microscopical study of structural barriers in microvessel clusters in highly malignant primary prostate carcinomas. Prostate 62:123–132 (10.1002/pros.20129) / Prostate by E Wieser (2004)
  247. Willis MC, Collins BD, Zhang T, Green LS, Sebesta DP, Bell C, Kellogg E, Gill SC, Magallanez A, Knauer S, Bendele RA, Gill PS, Janjić N (1998) Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem 9:573–582 (10.1021/bc980002x) / Bioconjug Chem by MC Willis (1998)
  248. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12:433–455 (10.1146/annurev.iy.12.040194.002245) / Annu Rev Immunol by G Winter (1994)
  249. Woods M, Woessner DE, Sherry AD (2006) Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 35:500–511 (10.1039/b509907m) / Chem Soc Rev by M Woods (2006)
  250. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP (2003) Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 21:41–46 (10.1038/nbt764) / Nat Biotechnol by X Wu (2003)
  251. Wu YL, Ye Q, Foley LM, Hitchens TK, Sato K, Williams JB, Ho C (2006) In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci USA 103:1852–1857 (10.1073/pnas.0507198103) / Proc Natl Acad Sci USA by YL Wu (2006)
  252. Xie YL, Lu W, Jiang XG (2006) Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav Brain Res 173:76–84 (10.1016/j.bbr.2006.06.001) / Behav Brain Res by YL Xie (2006)
  253. Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, Chung LW, Petros JA, O’Regan RM, Yezhelyev MV, Simons JW, Wang MD, Nie S (2007) Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc 2:1152–1165 (10.1038/nprot.2007.107) / Nat Protoc by Y Xing (2007)
  254. Xu M, Wang LV (2006) Biomedical photoacoustics. Rev Sci Instrum 77:04110101-22 / Rev Sci Instrum by M Xu (2006)
  255. Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, Cruz I, Xiang LM, Pirollo KF, Chang EH (2002) Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv immunoliposomes. Mol Cancer Ther 1:337–346 / Mol Cancer Ther by L Xu (2002)
  256. Yamashita T, Budhu A, Forgues M, Wang XW (2007) Activation of hepatic stem cell marker EpCAM by Wnt{beta}-catenin signaling in hepatocellular carcinoma. Cancer Res 67:10831–10839 (10.1158/0008-5472.CAN-07-0908) / Cancer Res by T Yamashita (2007)
  257. Yamawaki H, Iwai N (2006) Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ J 70:129–140 (10.1253/circj.70.129) / Circ J by H Yamawaki (2006)
  258. Yang HM, Ma JY, Castranova V, Ma JK (1997) Effects of diesel exhaust particles on the release of interleukin-1 and tumor necrosis factor-alpha from rat alveolar macrophages. Exp Lung Res 23:269–284 (10.3109/01902149709087372) / Exp Lung Res by HM Yang (1997)
  259. Yumoto R, Nishikawa H, Okamoto M, Katayama H, Nagai J, Takano M (2006) Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN. Am J Physiol Lung Cell Mol Physiol 290:L946–L955 (10.1152/ajplung.00173.2005) / Am J Physiol Lung Cell Mol Physiol by R Yumoto (2006)
  260. Zabow G, Dodd S, Moreland J, Koretsky A (2008) Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 453:1058–1063 (10.1038/nature07048) / Nature by G Zabow (2008)
  261. Zamboni WC, Goel S, Iqbal T, Parise RA, Sandra Strychor S, Repinski TVW, Egorin MJ, Mani S (2006) Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors. Cancer Chem Pharmacol 57:631–639 (10.1007/s00280-005-0084-6) / Cancer Chem Pharmacol by WC Zamboni (2006)
  262. Zelivyanskaya ML, Nelson JA, Poluektova L, Uberti M, Mellon M, Gendelman HE, Boska MD (2003) Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J Neurosci Res 73:284–295 (10.1002/jnr.10693) / J Neurosci Res by ML Zelivyanskaya (2003)
  263. Zhang Y, Pardridge WM (2001) Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Res 889:49–56 (10.1016/S0006-8993(00)03108-5) / Brain Res by Y Zhang (2001)
  264. Zhang Y, Zhu C, Pardridge WM (2002) Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 6:67–72 (10.1006/mthe.2002.0633) / Mol Ther by Y Zhang (2002)
  265. Zhang K, Maslov G, Stoica G, Wang LV (2006) Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat Biotechnol 24:848–851 (10.1038/nbt1220) / Nat Biotechnol by K Zhang (2006)
  266. Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer RS, Farokhzad OC (2007) Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle–aptamer bioconjugates. ChemMedChem 2:1268–1271 (10.1002/cmdc.200700121) / ChemMedChem by L Zhang (2007)
  267. Zhang S, Zhu X, Chen Z, Cai C, Lin T, Zhong J (2008) Improvement in the contrast of CEST MRI via intermolecular double quantum coherences. Phys Med Biol 53:N287–N296 (10.1088/0031-9155/53/14/N03) / Phys Med Biol by S Zhang (2008)
Dates
Type When
Created 16 years, 11 months ago (Sept. 29, 2008, 5:13 a.m.)
Deposited 7 months ago (Feb. 1, 2025, 3:05 a.m.)
Indexed 1 day, 10 hours ago (Sept. 3, 2025, 7:06 a.m.)
Issued 16 years, 11 months ago (Sept. 30, 2008)
Published 16 years, 11 months ago (Sept. 30, 2008)
Published Online 16 years, 11 months ago (Sept. 30, 2008)
Published Print 16 years, 10 months ago (Nov. 1, 2008)
Funders 0

None

@article{Debbage_2008, title={Molecular imaging with nanoparticles: giant roles for dwarf actors}, volume={130}, ISSN={1432-119X}, url={http://dx.doi.org/10.1007/s00418-008-0511-y}, DOI={10.1007/s00418-008-0511-y}, number={5}, journal={Histochemistry and Cell Biology}, publisher={Springer Science and Business Media LLC}, author={Debbage, Paul and Jaschke, Werner}, year={2008}, month=sep, pages={845–875} }